# FDA recall D-238-2013

> **Dr. Reddy'S Laboratories** · Class III · drug recall initiated 2013-03-19.

## Product

Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15.

## Reason for recall

Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.

## Distribution

Nationwide and Puerto Rico.

## Key facts

- **Recall number:** D-238-2013
- **Recalling firm:** Dr. Reddy'S Laboratories
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-03-19
- **Report date:** 2013-04-10
- **Termination date:** 2014-02-06

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Bridgewater, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-238-2013

## Citation

> AI Analytics. FDA recall D-238-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-238-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*